Sirio Pharma (300791) — Free Cash Flow Generation Index
Sirio Pharma (300791) has a Free Cash Flow Generation Index of 0.41x as of June 2023. Free cash flow of CN¥41.96 Million represents 0% of operating cash flow (CN¥101.61 Million). Read how much debt does Sirio Pharma carry for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sirio Pharma Free Cash Flow Generation Index (2017–2024)
Historical FCF Generation Index trend for Sirio Pharma across 8 annual periods. Explore how much does Sirio Pharma reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Sirio Pharma (2017–2024)
Year-by-year Free Cash Flow Generation Index for Sirio Pharma. For the full company profile including market capitalisation, see market value of Sirio Pharma.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.27x | CN¥154.84 Million | CN¥566.97 Million | CN¥412.13 Million | ▲ +260.7% |
| 2023 | -0.17x | CN¥-65.62 Million | CN¥386.08 Million | CN¥451.70 Million | ▼ -150.0% |
| 2022 | 0.34x | CN¥151.17 Million | CN¥444.86 Million | CN¥293.69 Million | ▲ +163.3% |
| 2021 | -0.54x | CN¥-183.31 Million | CN¥341.38 Million | CN¥524.68 Million | ▼ -278.0% |
| 2020 | 0.30x | CN¥96.43 Million | CN¥319.57 Million | CN¥223.14 Million | ▲ +8.0% |
| 2019 | 0.28x | CN¥64.71 Million | CN¥231.60 Million | CN¥166.90 Million | ▲ +191.7% |
| 2018 | -0.30x | CN¥-55.87 Million | CN¥183.46 Million | CN¥239.32 Million | ▲ +86.4% |
| 2017 | -2.24x | CN¥-110.47 Million | CN¥49.35 Million | CN¥159.82 Million | — |